文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血液系统恶性肿瘤相关脓毒症样休克中的紧急化疗

Urgent Chemotherapy in Sepsis-Like Shock Related to Hematologic Malignancies.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论血液系统恶性肿瘤相关脓毒症样休克患者接受紧急化疗后总体预后极差,仅3例出院存活,但化疗可能快速评估器官衰竭可逆性。

该研究为10年(2007—2016年)单中心回顾性研究,纳入17例需血管升压药的循环休克患者,休克在排除感染后推测与潜在血液系统恶性肿瘤相关,随后接受化疗。化疗后部分患者迅速死于难治性多器官衰竭,而早期存活者器官衰竭快速显著改善(改良SOFA评分下降)。总体预后差:ICU出院存活4例,医院出院存活3例,6个月和1年分别存活3例和2例。作者认为,化疗试验可能为器官衰竭可逆性提供快速预后评估。

要点

  • 纳入17例血液系统恶性肿瘤相关脓毒症样休克患者,休克需血管升压药且排除感染后推测与肿瘤相关。
  • 化疗后早期存活者器官衰竭快速显著改善,表现为改良SOFA评分(不含血小板)下降。
  • 总体预后差:ICU出院存活4例,医院出院存活3例,6个月存活3例,1年存活2例。
  • 部分患者化疗后迅速死于难治性多器官衰竭。
  • 作者认为化疗试验可能为器官衰竭可逆性提供快速预后评估。

适用人群与场景

  • 纳入2007—2016年单中心医疗ICU中需血管升压药的循环休克患者,休克在排除正在发生或新发感染过程后推测与潜在侵袭性血液系统恶性肿瘤相关,随后接受化疗。
  • 17例患者中包括13例非霍奇金淋巴瘤、2例高白细胞急性髓系白血病和2例「人类疱疹病毒8型」相关多中心Castleman病。

处置流程与药物剂量

  • 在排除正在发生或新发感染过程后,对推测与潜在恶性肿瘤相关的循环休克患者给予紧急化疗。
  • 促使紧急化疗的相关情况包括:肿瘤溶解综合征(n=10)、噬血细胞性淋巴组织细胞增生症(n=3)、压迫性巨大肿瘤(n=3)、肺部受累(n=3)和弥散性血管内凝血(n=1)。

研究设计与关键结果

  • 研究类型为10年(2007—2016年)单中心回顾性研究,纳入17例血液系统恶性肿瘤相关脓毒症样休克患者,无干预对照。
  • 化疗后部分患者迅速死于难治性多器官衰竭;早期存活者器官衰竭快速显著改善,表现为改良SOFA评分(不含血小板)下降。
  • 总体预后差:ICU出院存活4例,医院出院存活3例,6个月存活3例,1年存活2例。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于血液系统恶性肿瘤相关脓毒症样休克患者,在排除感染后,紧急化疗可能快速评估器官衰竭的可逆性,但总体预后极差(17例中仅3例出院存活)。
  • 作者认为,化疗试验可能为器官衰竭可逆性提供快速预后评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Hematologic malignancies may result in multiple organ involvement including pulmonary and renal dysfunctions, and the less common acute circulatory failure. We herein addressed the outcome of patients with sepsis-like shock related to aggressive hematologic malignancies.

DESIGN: A 10-year (2007-2016) monocenter retrospective study.

SETTINGS: A medical ICU in a tertiary care center.

PATIENTS: Patients with circulatory shock requiring vasopressors and who subsequently received chemotherapy. Shock was presumably related to the underlying malignancy after ruling out an ongoing or new-onset infectious process. The extent and time course of organ failures was assessed by a modified Sequential Organ Failure Assessment score devoid of the platelet component.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Seventeen patients were included, including 13 with non-Hodgkin lymphoma, two with hyperleukocytic acute myeloid leukemia, and two with "Human Herpes virus 8"-associated multicentric Castleman's disease. The following associated conditions prompted urgent administration of chemotherapy: tumor lysis syndrome (n = 10), hemophagocytic lymphohistiocytosis (n = 3), compressive bulky tumor (n = 3), pulmonary involvement (n = 3), and disseminated intravascular coagulation (n = 1). Following the initiation of chemotherapy, a number of patients died rapidly from untractable multiple organ failure. In contrast, chemotherapy led to a fast and dramatic improvement in organ failures in early survivors, as shown by the decrease in the modified Sequential Organ Failure Assessment score. However, the overall outcome was poor since only four and three patients could be discharged alive from the ICU and the hospital, and three and two patients remained alive at 6 months and 1 year.

CONCLUSIONS: Multiple organ dysfunction syndrome related to hematologic malignancies is associated with a dismal outcome. A chemotherapy trial may provide a fast prognostic assessment of the reversibility of organ failure.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cherruault M, Le Goff M, Tamburini J, et al. Urgent Chemotherapy in Sepsis-Like Shock Related to Hematologic Malignancies. Crit Care Med. 2018. PMID: 29373361. doi:10.1097/CCM.0000000000002990

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。